 |
|
Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke
The Framingham Offspring Study
Robert M. Najarian, MD;
Lisa M. Sullivan, PhD;
William B. Kannel, MD;
Peter W. F. Wilson, MD;
Ralph B. D’Agostino, PhD;
Philip A. Wolf, MD
Arch Intern Med. 2006;166:106-111.
Background Metabolic syndrome (MetS) has been recognized as a prediabetic constellation of symptoms and an independent risk factor for cardiovascular disease.
Methods To evaluate the age-adjusted risk of stroke and population-attributable risk associated with MetS and compare with those of overt type 2 diabetes mellitus (hereinafter, "diabetes"), we determined the prevalence of MetS alone, diabetes alone, and both in 2097 subjects in the Framingham Offspring Study, aged 50 to 81 years and free of stroke. Age-adjusted risk ratios, 10-year incidence, and population-attributable risks of stroke were estimated for men and women with MetS alone, diabetes alone, and both.
Results Criteria for MetS were met in 30.3% of men and 24.7% of women. Twenty-four percent of men had MetS alone; 7% had diabetes alone; and 6% had both. Twenty percent of women had MetS alone; 3% had diabetes alone; and 5% had both. Over 14 years of follow-up, 75 men and 55 women developed a first stroke; all but 4 events were ischemic. Relative risk (RR) of stroke in persons with both diabetes and MetS (RR, 3.28; confidence interval [CI], 1.82-5.92) was higher than that for either condition alone (MetS alone: RR, 2.10; CI, 1.37-3.22; diabetes alone: RR, 2.47; CI, 1.31-4.65). The population-attributable risk, owing to its greater prevalence, was greater for MetS alone than for diabetes alone (19% vs 7%), particularly in women (27% vs 5%).
Conclusions Metabolic syndrome is more prevalent than diabetes and a significant independent risk factor for stroke in people without diabetes. Prevention and control of MetS and its components are likely to reduce stroke incidence.
Author Affiliations: Departments of Neurology (Dr Najarian), Preventive Medicine (Dr Kannel), and Neurology (Dr Wolf), Boston University School of Medicine, and Department of Mathematics and Biostatistics, Boston University (Drs Sullivan and D’Agostino), Boston, Mass; Department of Endocrinology, Diabetes, and Medical Genetics, Medical University of South Carolina, Charleston (Dr Wilson). Dr Najarian is now with Beth Israel Deaconess Medical Center, Boston; Dr Kannel is now retired from Boston University and works as an investigator with the Framingham Heart Study.
RELATED LETTER
Stroke, Obstructive Sleep Apnea, and Disorders of Glucose Metabolism
Miguel A. Arias, Alberto Alonso-Fernández, and Francisco García-Río
Arch Intern Med. 2006;166(13):1418-1419.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Wang et al.
Stroke 2008;39:1078-1083.
ABSTRACT
| FULL TEXT
Metabolic Syndrome and Its Components as Predictors of Ischemic Stroke in Type 2 Diabetic Patients
Protopsaltis et al.
Stroke 2008;39:1036-1038.
ABSTRACT
| FULL TEXT
Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome
Lien et al.
Hypertension 2007;50:609-616.
ABSTRACT
| FULL TEXT
Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?
Blaum et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:766-773.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Arenillas et al.
Stroke 2007;38:2196-2203.
FULL TEXT
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study
Karvounaris et al.
Ann Rheum Dis 2007;66:28-33.
ABSTRACT
| FULL TEXT
Stroke, obstructive sleep apnea, and disorders of glucose metabolism.
Arias et al.
Arch Intern Med 2006;166:1418-1419.
FULL TEXT
Metabolic Syndrome and Stroke Risk
JWatch Neurology 2006;2006:1-1.
FULL TEXT
|
